SE465153B - Metylendioxifenantrenderivat, foerfarande foer framstaellning av detta och ett laekemedel - Google Patents

Metylendioxifenantrenderivat, foerfarande foer framstaellning av detta och ett laekemedel

Info

Publication number
SE465153B
SE465153B SE8603589A SE8603589A SE465153B SE 465153 B SE465153 B SE 465153B SE 8603589 A SE8603589 A SE 8603589A SE 8603589 A SE8603589 A SE 8603589A SE 465153 B SE465153 B SE 465153B
Authority
SE
Sweden
Prior art keywords
formula
compound
bromide
acid
och3
Prior art date
Application number
SE8603589A
Other languages
English (en)
Swedish (sv)
Other versions
SE8603589D0 (sv
SE8603589L (sv
Inventor
K Goerler
G Krumbiegel
M Hanack
L Subramanian
Original Assignee
Madaus Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Madaus Ag filed Critical Madaus Ag
Publication of SE8603589D0 publication Critical patent/SE8603589D0/xx
Publication of SE8603589L publication Critical patent/SE8603589L/xx
Publication of SE465153B publication Critical patent/SE465153B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/70—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with ring systems containing two or more relevant rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE8603589A 1985-08-28 1986-08-26 Metylendioxifenantrenderivat, foerfarande foer framstaellning av detta och ett laekemedel SE465153B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853530718 DE3530718A1 (de) 1985-08-28 1985-08-28 Methylendioxyphenanthren- und -stilbenderivate, verfahren zur herstellung derselben und arzneimittel, die diese enthalten

Publications (3)

Publication Number Publication Date
SE8603589D0 SE8603589D0 (sv) 1986-08-26
SE8603589L SE8603589L (sv) 1987-03-01
SE465153B true SE465153B (sv) 1991-08-05

Family

ID=6279566

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8603589A SE465153B (sv) 1985-08-28 1986-08-26 Metylendioxifenantrenderivat, foerfarande foer framstaellning av detta och ett laekemedel

Country Status (27)

Country Link
US (2) US4835178A (es)
JP (1) JPS62167776A (es)
KR (1) KR880000179B1 (es)
AR (1) AR242568A1 (es)
AT (1) AT398568B (es)
BE (1) BE905340A (es)
CH (1) CH673457A5 (es)
DD (1) DD266800A5 (es)
DE (1) DE3530718A1 (es)
DK (1) DK168705B1 (es)
ES (1) ES2001893A6 (es)
FI (1) FI92396C (es)
FR (1) FR2586681B1 (es)
GB (1) GB2179347B (es)
HU (3) HU199446B (es)
IE (1) IE59239B1 (es)
IT (1) IT1197467B (es)
LU (1) LU86556A1 (es)
MX (2) MX172917B (es)
NL (1) NL8602127A (es)
NO (1) NO863434L (es)
PL (2) PL148757B1 (es)
PT (1) PT83258B (es)
SE (1) SE465153B (es)
SU (1) SU1731053A3 (es)
YU (2) YU44061B (es)
ZA (1) ZA866487B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0432983A3 (en) * 1989-12-15 1991-08-21 Pharma Mar, S.A. Novel compounds of the diterpene type
ATE116637T1 (de) * 1991-02-05 1995-01-15 Merrell Dow Pharma Sulfonische stilbenderivate zur behandlung von viruserkrankungen.
ATE165345T1 (de) * 1992-02-20 1998-05-15 Merrell Pharma Inc Sulfonsaeurederivate zur behandlung von viruserkrankungen
US5334615A (en) * 1992-12-17 1994-08-02 Walles Wilhelm E Oil with bactericidal and virucidal properties
US5739166A (en) * 1994-11-29 1998-04-14 G.D. Searle & Co. Substituted terphenyl compounds for the treatment of inflammation
CN112778264B (zh) * 2021-01-21 2023-09-15 江西农业大学 马兜铃次酸衍生物及其在制备抗炎药物中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4122092A (en) * 1977-08-25 1978-10-24 University Of Rochester Total synthesis of (±)-picropodophyllone and (±)-4'-demethylpicropodophyllone
JPS57106677A (en) * 1980-12-22 1982-07-02 Kureha Chem Ind Co Ltd N-(3,4-methylenedioxybenzylidene) aminomethylcyclohexane-carboxylic acid, and salt of said carboxylic acid

Also Published As

Publication number Publication date
YU44061B (en) 1990-02-28
JPS62167776A (ja) 1987-07-24
ES2001893A6 (es) 1988-07-01
GB2179347B (en) 1989-08-09
BE905340A (fr) 1987-02-27
GB2179347A (en) 1987-03-04
JPH0349908B2 (es) 1991-07-31
FI863282A (fi) 1987-03-01
HU199446B (en) 1990-02-28
PL268178A1 (en) 1988-10-13
SE8603589D0 (sv) 1986-08-26
NO863434D0 (no) 1986-08-27
AR242568A1 (es) 1993-04-30
NO863434L (no) 1987-03-02
DE3530718A1 (de) 1987-03-12
FR2586681B1 (fr) 1991-02-22
DK407586D0 (da) 1986-08-27
SU1731053A3 (ru) 1992-04-30
PL148757B1 (en) 1989-11-30
YU43998B (en) 1990-02-28
PT83258B (pt) 1988-07-01
LU86556A1 (fr) 1986-12-02
HU895304D0 (en) 1990-03-28
DK168705B1 (da) 1994-05-24
MX3550A (es) 1993-10-01
US5024743A (en) 1991-06-18
MX9300436A (es) 1994-07-29
HUT44775A (en) 1988-04-28
GB8619644D0 (en) 1986-09-24
DE3530718C2 (es) 1992-07-09
PL261196A1 (en) 1988-02-04
MX172917B (es) 1994-01-21
FR2586681A1 (fr) 1987-03-06
FI863282A0 (fi) 1986-08-13
IT8621526A0 (it) 1986-08-26
YU147586A (en) 1988-02-29
PL154026B1 (en) 1991-06-28
IT1197467B (it) 1988-11-30
YU114987A (en) 1988-02-29
KR870002119A (ko) 1987-03-30
FI92396C (fi) 1994-11-10
DK407586A (da) 1987-03-01
SE8603589L (sv) 1987-03-01
ZA866487B (en) 1987-04-29
IE59239B1 (en) 1994-01-26
NL8602127A (nl) 1987-03-16
US4835178A (en) 1989-05-30
PT83258A (de) 1986-09-01
ATA215186A (de) 1994-05-15
DD266800A5 (de) 1989-04-12
FI92396B (fi) 1994-07-29
IE862288L (en) 1987-02-28
KR880000179B1 (ko) 1988-03-12
CH673457A5 (es) 1990-03-15
HU202104B (en) 1991-02-28
AT398568B (de) 1994-12-27

Similar Documents

Publication Publication Date Title
JP2950616B2 (ja) トリテルペン誘導体
TW442490B (en) Tricyclic erythromycin derivatives
JPS62155250A (ja) フエノキシアルキルカルボン酸およびエステル化合物，その製造方法および該化合物を含有する医薬組成物
SE465153B (sv) Metylendioxifenantrenderivat, foerfarande foer framstaellning av detta och ett laekemedel
TW200845956A (en) Calcilytic compounds
WO2016173308A1 (zh) 大环内酯类衍生物及其用途
HU194862B (en) Process for preparing dithio compounds and pharmaceuticals comprising the same
JP3909864B2 (ja) ナフチルオキシ酢酸誘導体およびそれらを有効成分として含有する薬剤
WO1990007494A1 (fr) Nouveau derive d'hydroxylamine
US3098076A (en) 1, 1-diphenyl-2-tertiary aminomethyl-3-hydroxy methyl-cyclopropanes and esters thereof
Fletcher Jr et al. Evidence that Racemic Arabinose is β-d, l-Arabinopyranose
JP2007246493A (ja) タモキシフェン類縁体を有効成分として含有する血管新生抑制剤
EP0096008B1 (en) (+)-cyanidan-3-ol derivatives, processes for their manufacture, pharmaceutical preparations that contain such compounds, and the use of the latter
JP7350854B2 (ja) Ｆｘｒ作動薬の固体形態、結晶形態、結晶体ａ、その調製方法および応用
US6335366B2 (en) Naphthyloxy acetic acid derivatives and a pharmaceutical composition comprising them as an active ingredient
US3865838A (en) (5-Indolyloxy)-acetic acid compounds and therapeutic compositions
US3816480A (en) -oxygenated 21-dialkylamino-20-methyl-5alpha-pregn-17(20)-dien-3-ones and congeners
DK144564B (da) Analogifremgangsmaade til fremstilling af symmetriske methylsubstituerede 3,14-dithia-1,16-hexadecandioler
JPH03120277A (ja) １３―プロム―及び１３，１４―ジブロム―エルゴリン、その製法、その中間体及びこれらを含有するパーキンソン病治療用薬剤
NO175635B (es)
JP3264750B2 (ja) キサントン誘導体、およびその製造法ならびに使用法
GB2080796A (en) 2-Hydroxy-5-phenylazobenzoic acid derivatives
JPS6338991B2 (es)
NO174808B (no) Fremgangsmåte for fremstilling av terapeutisk aktive metylendioksyfenantren-derivater
JPS6355487B2 (es)

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8603589-6

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8603589-6

Format of ref document f/p: F